Curatis, Public Offering Price 4,000 Won... Below Desired Range Level

Curatis announced on the 2nd that it has finalized the public offering price at 4,000 KRW after conducting a demand forecast targeting institutional investors. This is below the expected range of 6,500 to 8,000 KRW.

A total of 435 institutions participated in the demand forecast held on the 30th and 31st of last month, recording a final competition rate of 52.89 to 1.

Curatis plans to proceed with subscription for general investors on the 5th and 7th, and is scheduled to be listed on the KOSDAQ market on the 15th. The lead underwriters are Daishin Securities and ShinYoung Securities.

Curatis is a vaccine and immune disease treatment company established in 2016, developing the adult and adolescent tuberculosis vaccine 'QTP101'.